It has been reported that women are more susceptible to poor outcomes, such as in-hospital mortality, depression and disability, than men after ischaemic stroke. However, the relationship between sex differences and outcomes after aSAH remains controversial3. Consequently, the present study aims to investigate the sex differences in aSAH patients in terms of discharge outcomes and epidemiology and to analyse the risk factors for dependent survival in patients of different sexes. In turn, this study will provide valuable information for clinical practice and aid clinical doctors in making suitable decisions for such patients. As we have seen, this is the largest consecutive, multicentre, observational study reporting the role of sex in short-term outcomes and risk factors for dependent survival following aSAH.
In this study, 5407 patients were included, and the ratio of females to males was 1.8:1. We found female to male ratios ranging from 0.6:1 to 3.2:1 according to age. This was similar to some established studies that showed that the male to female ratios ranged from 1:1.2 to 1:3.19–11. This female preponderance was also shown in studies that compared unruptured and ruptured aneurysms, which demonstrated a sex difference in aSAH prevalence7,12. In this study, the number of female patients began to exceed that of male patients in the 5th decade, and the peak incidence of aSAH occurred in the 7th decade in female patients and in the 6th decade in male patients. Decreased levels of the sex hormone oestrogen after menopause have been suspected to contribute to this phenomenon because menopause in females usually occurs in the late 5th and early 6th decades. Oestrogen can promote normal endothelial function and decrease the loss of collagen and elastin in the vascular wall, weakening vascular wall integrity13.
Decreased levels of sex hormonal influences on vascular wall remodelling were also the reasons for these sex differences in aneurysm multiplicity. Juvela et al.6 reported that female patients had an increased tendency to have multiple aneurysms after adjusting for smoking status. A study including 1277 aSAH patients also showed that female sex was a risk factor for presenting with 2 or more aneurysms14. In the present study, we also found that the incidence of multiple aneurysms was significantly higher in female patients (21.5%) than in male patients (14.2%).
This study also showed that female patients had more ICA/PCoA aneurysms, and male patients had more ACA/ACoA aneurysm. Haemodynamics and Circle of Willis anatomy may play a role in sex differences in aneurysm location. ACoA aneurysm is associated with Type A anatomy of Circle of Willis, which is more common in males, and ICA aneurysm is related to Type P anatomy, which is more commonly seen in females15. And the parent artery diameter and branches are smaller in females than in males, and the maximum wall shear stress of ICA bifurcation in women is 50% higher than that in men, which also increases the risk of aneurysm formation16.
Most studies have reported that there is no significant correlation between outcomes after aSAH and sex9,17–20. In this study, there were also no significant differences in terms of dependent survival or mortality between female and male patients at discharge before and after PSM. However, a large cohort international trialist repository included 8051 aSAH patients and demonstrated that female sex was correlated with poor functional outcome31. Some studies have reported that females have worse quality of life and higher recurrence rates after aSAH14,19. Vasospasm may play a role in the outcomes of different sexes. Rosenłrn et al.21 reported that females have a higher vasospasm rate than males. Some studies found that female sex was a risk factor for vasospasm after aSAH22. Catecholamines can stimulate the sympathetic nervous system, which plays a role in vasospasm. Higher noradrenaline was found in female patients by Lambert et al.23 Because of the limitations of this retrospective study, we could not investigate the association between poor outcome and vasospasm. This information shows that the relationship between sex differences and outcomes after aSAH remains controversial, and more evidence within this topic is needed in future studies.
To clarify which factors might affect the discharge outcome of male or female patients, the present study also analysed the risk factors for dependent survival in female and male patients. We found that dependent survival was only related to the clinical condition on admission, such as CT Fisher grade, H-H grade and WFNS, in female aSAH patients. In addition to clinical conditions on admission, age older than 50 years and hypertension were also risk factors for dependent survival in male patients. Operative treatment would reduce the odds ratios of dependent survival in both female and male patients. Interestingly, smoking could reduce the risk of dependent survival in males. Dasenbrock et al.24 also reported that smoking was related to decreased odds of poor outcome (OR 0.53, 95% CI 0.41–0.69, P < 0.05) and in-hospital mortality (OR 0.69, 95% CI 0.50–0.96, P < 0.05). Some studies found that transdermal nicotine replacement after aSAH was related to good clinical outcomes among smokers and a decreased risk of death 3 months after onset but a similar incidence of delayed cerebral ischaemia compared with smokers who did not receive nicotine25,26. This may be associated with the neuroprotective effects of nicotine. Because of the nicotinic acetylcholine receptors on intracranial vessels, nicotine might have neurogenic vasodilatory and anti-inflammatory effects26. In contrast, more studies have shown that smoking is associated with poor outcomes and vasospasm27,28. Because of the limitations of retrospective studies, smoking included former smoking and current smoking and was not stratified by smoking status in this study. We will perform prospective studies to clarify the role of smoking on the outcomes of aSAH patients.
Limitations
The results of the present study are subject to the limitations of a multicentre retrospective study based on clinical medical records. For example, we could not obtain detailed information on smoke exposure and aneurysm diameter.